In this community-based HCC screening on an aged population in an HCV-endemic township, we found that platelet count and AFP could be feasible markers for high-risk patient identification and ...

Hepatocellular carcinoma (HCC) is a primary liver malignancy that typically develops in the setting of chronic liver disease. It is the 4th leading cause of cancer Worldwide with a five-year survival ...

After further studies and intensive follow up, there were 16 confirmed HCC cases within 1 year after screening. As shown in Table 1, the PPV of AFP was 38.9%, which was much higher than the ...

Genetron Health has developed a blood-based early screening test called HCCscreen™, which is capable of detecting the biological changes that are associated with hepatocellular carcinoma (HCC ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. Screening efforts for this cancer focus on ...

Fujifilm Middle East and Africa part of the globally renowned Fujifilm Corporation is participating at Arab Health 2025 ...

Fujifilm Middle East and Africa, part of the globally renowned Fujifilm Corporation, participates at Arab Health 2025, taking ...